SHARE TRANSFER AGREEMENTShare Transfer Agreement • January 3rd, 2023 • PDS Biotechnology Corp • Pharmaceutical preparations • Delaware
This Share Transfer Agreement (this “Agreement”) is made effective as of December 30, 2022 (the “Effective Date”), by and between PDS Biotechnology Corporation, a Delaware corporation (the “Company”), and Merck KGaA, Darmstadt, Germany, a corporation with general partners organized under German law (the “Investor”).
